Johnson & Johnson hit with $8 billion jury verdict in breast tissue suit


A jury in Philadelphia ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who says the drug Risperdal caused him to grow breast tissue. The lawsuit claimed the drugmaker downplayed the risk of breast tissue growth in boys.